-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NVy6F69aCMrf95KYqkOaU1m9XCNV5MIA6yRYVulYrB3XcOMqRT42gwELRtX6ao6p HVfDkj+RV2c/J8CaQnOxzQ== 0000875320-11-000018.txt : 20110224 0000875320-11-000018.hdr.sgml : 20110224 20110224163313 ACCESSION NUMBER: 0000875320-11-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110223 FILED AS OF DATE: 20110224 DATE AS OF CHANGE: 20110224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sachdev Amit CENTRAL INDEX KEY: 0001406338 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 11636725 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2011-02-23 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001406338 Sachdev Amit C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 0 1 0 0 SVP, Corp Affairs & Pub Policy Common Stock 2011-02-23 4 M 0 23828 18.93 A 67954 D Common Stock 2011-02-23 4 S 0 11914 43.60 D 56040 D Common Stock 2011-02-23 4 S 0 11914 44.00 D 44126 D Common Stock 410 I 401(k) Stock Option 18.93 2011-02-23 4 M 0 23828 0 D 2008-05-15 2018-02-06 Common Stock 23828 21446 D Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/07/2008, except that the first quarterly vesting occurred on May 15, 2008. Kenneth S. Boger, Attorney-In-Fact 2011-02-24 -----END PRIVACY-ENHANCED MESSAGE-----